TrialBMC cancer2022

SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?

Kato Rans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.